Delivery Order SPE2DB20D1109-SPE2DB25FP41X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (5-count) on July 24, 2025, with a contract ceiling value of $1,698.52 and ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was performed at the vendor's corporate...
- The Defense Logistics Agency awarded a $12,392.75 delivery order to AmerisourceBergen Drug Corp for the supply of Aprepitant 125 mg capsules (unit dose, 6 count packaging) with a completion date of July 31, 2025. This non-set-aside, firm fixed price contract was awarded competitively on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a $4,792 delivery order to Amerisourcebergen Drug Corporation for 4562020402 Aprepitant 40 mg capsules under a firm fixed price contract. The order is for an unspecified quantity of the drug to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 1, 2023 to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the larger vehicle or any subcontractors involved. The...
- The Defense Logistics Agency Troop Support Medical awarded a $2,194.18 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561604184 APREPITANT 40 MG CAPSULE UD 5S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for the delivery of the specified pharmaceutical product and has a period of performance from July 26, 2023 through July 27, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the...
- The Defense Logistics Agency awarded a $6,105.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561555372 APREPITANT 80 MG CAPSULE UD 6S. The place of performance is Conshohocken, Pennsylvania. The start date is July 20, 2023 and the end date is July 21, 2023. This delivery order was issued against an unspecified indefinite-delivery/indefinite-quantity contract vehicle to supply the Defense Logistics Agency with the specified pharmaceutical product. No...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Aprepitant 40 mg capsules. The Delivery Order, valued at $5,369.62, has a firm fixed price and an ultimate completion date of July 24, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation noted. The contract is likely part of a larger Indefinite Delivery Contract (IDC) vehicle held by...
- The Defense Logistics Agency Troop Support Medical awarded a $1,449 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division. The contract is to provide 4562251482 APREPITANT 40 MG CAPSULE UD 5S from the contractor's facility in Conshohocken, Pennsylvania. No additional details were provided about the original solicitation or whether this delivery order is associated with any broader indefinite-delivery/indefinite-quantity contracts. The award was made...
- This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,788.48, is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a type of prescription medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP41XDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,459.88 to AmerisourceBergen Drug Corp for Aprepitant 40 mg capsule unit dose packages (quantity 5) on July 18, 2025, with completion scheduled for July 21, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued as a child contract under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Aprepitant is an antiemetic medication commonly used in military and federal healthcare settings for chemotherapy-induced nausea and vomiting management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/18/25 |